PSC
Patient Square Capital Portfolio holdings
AUM
$467M
1-Year Est. Return
175.86%
This Fund
S&P 500
1 Year Est. Return
+175.86%
AUM
$374M
AUM Growth
+$96.5M
(+35%)
Holding
27
Top Buys
| 1 | +$9.31M | |
| 2 | +$6.76M | |
| 3 | +$4M | |
| 4 |
Dianthus Therapeutics
DNTH
|
+$3.19M |
| 5 |
Amylyx Pharmaceuticals
AMLX
|
+$2.98M |
Top Sells
| 1 | +$13.4M | |
| 2 | +$8.9M | |
| 3 | +$6.54M | |
| 4 |
Scholar Rock
SRRK
|
+$5.45M |
| 5 |
Insmed
INSM
|
+$3.97M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Scholar Rock
SRRK
$5.23B
| – | – |
-154,000
|
|
||
27
VYNE Therapeutics
VYNE
$20.8M
| – | – |
-317,033
|
|